[go: up one dir, main page]

AU6124494A - Ophthalmic uses of signa agonists - Google Patents

Ophthalmic uses of signa agonists

Info

Publication number
AU6124494A
AU6124494A AU61244/94A AU6124494A AU6124494A AU 6124494 A AU6124494 A AU 6124494A AU 61244/94 A AU61244/94 A AU 61244/94A AU 6124494 A AU6124494 A AU 6124494A AU 6124494 A AU6124494 A AU 6124494A
Authority
AU
Australia
Prior art keywords
signa
agonists
ophthalmic uses
ophthalmic
signa agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61244/94A
Inventor
Charles F. Barfknecht
Roger E. Newton
Ronald D. Schoenwald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
Original Assignee
University of Iowa Research Foundation UIRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation UIRF filed Critical University of Iowa Research Foundation UIRF
Publication of AU6124494A publication Critical patent/AU6124494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU61244/94A 1993-01-28 1994-01-18 Ophthalmic uses of signa agonists Abandoned AU6124494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1034793A 1993-01-28 1993-01-28
US010347 1993-01-28
PCT/US1994/000591 WO1994016685A1 (en) 1993-01-28 1994-01-18 Ophthalmic uses of signa agonists

Publications (1)

Publication Number Publication Date
AU6124494A true AU6124494A (en) 1994-08-15

Family

ID=21745317

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61244/94A Abandoned AU6124494A (en) 1993-01-28 1994-01-18 Ophthalmic uses of signa agonists

Country Status (2)

Country Link
AU (1) AU6124494A (en)
WO (1) WO1994016685A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
BR0109317A (en) 2000-07-14 2003-06-17 Allergan Inc Compositions containing alpha-2-adrenergic agonist components
DK2153819T3 (en) 2000-07-14 2012-12-03 Allergan Inc Use of a solubility enhancing component in an aqueous composition comprising brimonidine tartrate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820737A (en) * 1987-02-17 1989-04-11 University Of Iowa Research Foundation Lacrimal secretion stimulant (lss)
WO1992017175A1 (en) * 1991-03-29 1992-10-15 University Of Iowa Research Foundation Ophthalmic uses of sigma site binders

Also Published As

Publication number Publication date
WO1994016685A1 (en) 1994-08-04

Similar Documents

Publication Publication Date Title
AU6072994A (en) Tri-carbamate-functional crosslinking agents
AU7159994A (en) 3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives
AU6001594A (en) Imidazoazines
AU1072695A (en) Dressing
AU1248395A (en) Bandages
AU6405094A (en) Tampon
AU7157494A (en) Tocopherols
AU7425594A (en) Breakout
AU6571594A (en) Thioindole pyperidinyl derivatives used as antalgics
AU6723294A (en) Use of simmondsine
AU6614694A (en) An ocular hypotensive agent
AU6337294A (en) Ophthalmic topical agent
AU6544294A (en) Polystyrene-dissolving agent
AU6259294A (en) Life-savingfloat
AU8119594A (en) Use of low anticoagulant heparinderivatives
AUPM300993A0 (en) Instrument
AU6021794A (en) Ophthalmic compositions comprising benzyllauryldimethylammonium chloride
AU6511294A (en) Tonometer
AU5888094A (en) Adjustable spectacles
AU6532690A (en) Lashing eye
AU6124494A (en) Ophthalmic uses of signa agonists
AU4834593A (en) Masking member
AU6973194A (en) Composition for ophthalmic use
AU1274295A (en) Heteroarylpyrroles
AU8110494A (en) Bandages